FDA committee moves Pfizer-BioNTech COVID-19 vaccine closer to use for children ages 5-11
In children ages 5-11, the Pfizer-BioNTech vaccine was more than 90% protective against contracting symptomatic COVID-19, according to company data.
Karen Weintraub and Elizabeth Weise, USA TODAY
Pfizer-BioNTech COVID-19 vaccine becomes first to win FDA’s full approval, paving way for boosters, mandates
The FDA’s decision to fully license the Pfizer-BioNTech COVID-19 vaccine is likely to trigger more mandates and allow marketing of the shot.